IP Library Patent Application 12286527
Patent Application
App. No. 12/286,527

Histological facilitation systems and methods

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/286,527
Abstract

Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described.

Claims (73)

1 . A medical or veterinary system comprising:

first means for bearing device-detectable data indicating a treatment of a tissue component in a chamber extended into tissue of an organism; and

second means for indicating the treatment of the tissue component.

2 . An apparatus comprising:

one or more physical media bearing device-detectable data indicating a treatment of a tissue component in a chamber extended into tissue of an organism.

3 . The apparatus of claim 2 , further comprising:

a device containing the chamber, positioned with a handling control surface.

4 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises:

output from a device positioned with a handling control surface.

5 - 8 . (canceled)

9 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises: image data depicting a cell of the tissue component.

10 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises:

image data depicting frozen tissue including the tissue component.

11 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises:

a signal from a probe that was positioned adjacent the tissue component in vivo.

12 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises:

a signal from a surgical instrument that was positioned adjacent the tissue component.

13 . The apparatus of claim 2 in which the one or more physical media further comprises:

an image of the tissue component from an electron microscope.

14 . The apparatus of claim 2 in which the one or more physical media further comprises:

an image of the tissue component from laser-scanning equipment.

15 . The apparatus of claim 2 in which the one or more physical media further comprises:

some of the one or more physical media bearing a signal from a biosensor.

16 . The apparatus of claim 2 in which the one or more physical media further comprises:

a result of an in situ hybridization protocol performed upon some of the tissue component.

17 . The apparatus of claim 2 in which the one or more physical media further comprises:

a result of positioning at least some of the tissue component in a microfluidic structure.

18 . The apparatus of claim 2 in which the one or more physical media further comprises:

some of the one or more physical media bearing a result of the treatment including one or more antibodies.

19 . The apparatus of claim 2 in which the one or more physical media further comprises:

a result of material applied in vivo indicating an absence of or a presence of a first attribute in the tissue component

20 . The apparatus of claim 2 in which the one or more physical media further comprises:

some of the one or more physical media bearing a portion of the device-detectable data received from one or more chemical sensors.

21 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises:

a karyotype of the organism.

22 . (canceled)

23 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises:

a data component relating to fluid extracted from the organism.

24 . The apparatus of claim 2 in which the device-detectable data indicating the treatment of the tissue component in the chamber comprises:

an extraction protocol descriptor.

25 . (canceled)

26 . The apparatus of claim 2 in which the device-detectable data comprises:

one or more identifiers of a protocol by which the tissue component was frozen.

27 . The apparatus of claim 2 in which the device-detectable data comprises:

one or more identifiers of a protocol by which the tissue component was optically treated.

28 . (canceled)

29 . The apparatus of claim 2 in which the device-detectable data comprises:

one or more identifiers of a marking agent by which the tissue component was chemically treated.

30 . The apparatus of claim 2 in which the device-detectable data comprises:

a go/no-go indication relating to the tissue component.

31 . The apparatus of claim 2 in which the device-detectable data comprises:

a go/no-go indication of an extraction of the tissue component.

32 . The apparatus of claim 2 in which the device-detectable data comprises:

a laser-scanned image of at least some of a cell to which an optical enhancement material of the treatment was applied in vivo.

33 . The apparatus of claim 2 in which the device-detectable data comprises:

an earlier image depicting the tissue component unfrozen; and

a later image depicting the tissue component frozen.

34 - 37 . (canceled)

38 . The apparatus of claim 2 , further comprising:

circuitry for causing chemically treated tissue to be frozen in vivo in response to contemporaneous user input.

39 - 42 . (canceled)

43 . The apparatus of claim 2 , further comprising:

one or more other physical media bearing an operational setting value usable in laser scanning equipment for analyzing a portion of the tissue.

44 - 51 . (canceled)

52 . The apparatus of claim 2 in which the treatment comprises:

a permeabilizing agent.

53 - 59 . (canceled)

60 . The apparatus of claim 2 in which a portion of the one or more physical media comprises:

one or more size-descriptive quantities relating to the tissue component.

61 - 75 . (canceled)

76 . The apparatus of claim 2 , further comprising:

a nuclear magnetic resonance imaging system configured to observe the tissue component in the chamber and to provide at least some of the device-detectable data on the one or more physical media.

77 - 99 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: SEARETE LLC
To: DEEP SCIENCE, LLC
Reel/Frame 037535/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2009
From: HYDE, RODERICK A.; ISHIKAWA, MURIEL Y.; OLSON, JONATHAN E.; LEUTHARDT, ERIC C.; RIVET, DENNIS J.; WOOD JR., LOWELL L.; WOOD, VICTORIA Y.H.
To: SEARETE LLC
Reel/Frame 022059/0792 →